Antisense	O
oligonucleotides	O
to	O
the	O
p65	B-protein
subunit	I-protein
of	O
NF-kappa	B-protein
B	I-protein
block	O
CD11b	B-protein
expression	O
and	O
alter	O
adhesion	O
properties	O
of	O
differentiated	O
HL-60	B-cell_line
granulocytes	I-cell_line
.	O

NF-kappa	B-protein
B	I-protein
is	O
a	O
pleiotropic	B-protein
regulator	I-protein
of	O
a	O
variety	O
of	O
genes	O
implicated	O
in	O
the	O
cellular	O
response	O
to	O
injury	O
.	O

This	O
function	O
has	O
been	O
attributed	O
to	O
the	O
coordinated	O
binding	O
of	O
subunits	O
of	O
NF-kappa	B-protein
B	I-protein
to	O
distinct	O
regions	O
of	O
the	O
promoter	B-DNA
elements	I-DNA
of	O
numerous	O
genes	O
,	O
including	O
cytokines	B-protein
,	O
growth	B-protein
factor	I-protein
receptors	I-protein
,	O
and	O
adhesion	B-protein
molecules	I-protein
.	O

Antisense	O
phosphorothioate	O
oligonucleotides	O
to	O
the	O
p50	B-protein
and	O
p65	B-protein
subunits	I-protein
of	O
the	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
were	O
used	O
to	O
define	O
the	O
physiologic	O
role	O
of	O
this	O
transcription	B-protein
factor	I-protein
in	O
resting	B-cell_line
and	I-cell_line
stimulated	I-cell_line
granulocytes	I-cell_line
.	O

A	O
reduction	O
in	O
the	O
expression	O
of	O
p65	B-protein
was	O
produced	O
by	O
treatment	O
with	O
the	O
phosphorothioate	O
antisense	O
oligodeoxynucleotide	O
.	O

This	O
reduction	O
was	O
accompanied	O
by	O
rapid	O
changes	O
in	O
the	O
cellular	O
adhesion	O
of	O
dimethyl	B-cell_line
sulfoxide-differentiated	I-cell_line
HL-60	I-cell_line
leukemia	I-cell_line
cells	I-cell_line
stimulated	O
by	O
12-O-tetradecanoylphorbol	O
13-acetate	O
(	O
TPA	O
)	O
.	O

These	O
effects	O
were	O
characterized	O
by	O
a	O
marked	O
reduction	O
in	O
CD11b	B-protein
integrin	B-protein
expression	O
on	O
the	O
surface	O
of	O
treated	B-cell_line
cells	I-cell_line
.	O

Furthermore	O
,	O
the	O
p65	B-protein
antisense	O
oligomer	O
effectively	O
abolished	O
an	O
upregulation	O
of	O
CD11b	B-protein
that	O
was	O
produced	O
by	O
formyl-met-leu-phe	O
and	O
TPA	O
.	O

However	O
,	O
the	O
p65	B-protein
antisense	O
phosphorothioate	O
oligodeoxynucleotide	O
had	O
no	O
significant	O
effect	O
on	O
the	O
production	O
of	O
reactive	O
oxygen	O
intermediates	O
or	O
on	O
phagocytosis	O
by	O
these	O
cells	O
.	O

These	O
findings	O
indicate	O
that	O
antisense	O
oligomers	O
to	O
p65	B-protein
can	O
be	O
used	O
to	O
define	O
the	O
role	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
the	O
activation	O
pathways	O
of	O
neutrophils	B-cell_type
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Antisense	NULL
Oligonucleotides	NULL
to	NULL
the	NULL
p65	NULL
Subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Block	NULL
CD11b	NULL
Expression	NULL
and	NULL
Alter	NULL
Adhesion	NULL
Properties	NULL
of	NULL
Differentiated	NULL
HL-60	NULL
Granulocytes	NULL
By	NULL
John	NULL
A.	NULL
Sokoloski	NULL
,	NULL
Alan	NULL
C.	NULL
Sartorelli	NULL
,	NULL
Craig	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
Ramaswamy	NULL
Narayanan	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
pleiotropic	NULL
regulator	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
implicated	NULL
in	NULL
the	NULL
cellular	NULL
response	NULL
to	NULL
injury	NULL
.	NULL

This	NULL
function	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
the	NULL
coordinated	NULL
binding	NULL
of	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
distinct	NULL
regions	NULL
of	NULL
the	NULL
promoter	NULL
elements	NULL
of	NULL
numerous	NULL
genes	NULL
,	NULL
including	NULL
cytokines	NULL
,	NULL
growth	NULL
factor	NULL
receptors	NULL
,	NULL
and	NULL
adhesion	NULL
molecules	NULL
.	NULL

Antisense	NULL
phosphorothioate	NULL
oligonucleotides	NULL
to	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
were	NULL
used	NULL
to	NULL
define	NULL
the	NULL
physiologic	NULL
role	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
resting	NULL
and	NULL
stimulated	NULL
granulocytes	NULL
.	NULL

A	NULL
reduction	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
p65	NULL
was	NULL
produced	NULL
by	NULL
treatment	NULL
with	NULL
the	NULL
phosphorothioate	NULL
antisense	NULL
oligodeoxy-nucleotide	NULL
.	NULL

This	NULL
reduction	NULL
was	NULL
accompanied	NULL
by	NULL
rapid	NULL
changes	NULL
in	NULL
the	NULL
cellular	NULL
adhesion	NULL
of	NULL
dimethyl	NULL
sulfoxide-dif-	NULL
HE	NULL
NF-	NULL
«	NULL
B	NULL
TRANSCRIPTION	NULL
factor	NULL
complex	NULL
is	NULL
a	NULL
pleiotropic	NULL
activator	NULL
that	NULL
participates	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
numerous	NULL
cellular	NULL
and	NULL
viral	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
Ig	NULL
«	NULL
,	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
,	NULL
and	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
I	NULL
.	NULL
'	NULL

''	NULL
The	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
,	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
are	NULL
members	NULL
of	NULL
a	NULL
rapidly	NULL
growing	NULL
class	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
have	NULL
unique	NULL
amino	NULL
terminal	NULL
DNA	NULL
binding	NULL
and	NULL
dimer-ization	NULL
domains	NULL
.	NULL

*	NULL
``	NULL
The	NULL
genes	NULL
encoding	NULL
p50°	NULL
and	NULL
p65*~	NULL
have	NULL
recently	NULL
been	NULL
cloned	NULL
,	NULL
and	NULL
the	NULL
amino	NULL
termini	NULL
.	NULL

of	NULL
both	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
considerable	NULL
homology	NULL
with	NULL
the	NULL
re/	NULL
oncogene	NULL
product	NULL
.	NULL

The	NULL
re/	NULL
oncogene	NULL
,	NULL
originally	NULL
described	NULL
as	NULL
the	NULL
avian	NULL
retrovirus	NULL
Rev	NULL
T	NULL
,	NULL
causes	NULL
lymphoid	NULL
cell	NULL
tumors	NULL
in	NULL
birds	NULL
.	NULL

*	NULL
NF-	NULL
«	NULL
B	NULL
also	NULL
has	NULL
homology	NULL
with	NULL
the	NULL
dorsal	NULL
gene	NULL
product	NULL
of	NULL
Drosophila	NULL
melanogaster	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
we	NULL
provided	NULL
evidence	NULL
that	NULL
the	NULL
p65	NULL
subunit	NULL
is	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
.	NULL
'	NULL

''	NULL
More	NULL
specifically	NULL
,	NULL
domains	NULL
in	NULL
p65	NULL
that	NULL
lie	NULL
close	NULL
to	NULL
the	NULL
domain	NULL
that	NULL
specifies	NULL
DNA	NULL
binding	NULL
may	NULL
affect	NULL
the	NULL
formation	NULL
of	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
with	NULL
p50	NULL
as	NULL
well	NULL
as	NULL
DNA	NULL
binding	NULL
.	NULL

Thus	NULL
,	NULL
p65	NULL
may	NULL
interact	NULL
with	NULL
certain	NULL
domains	NULL
of	NULL
its	NULL
own	NULL
and/or	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
p50	NULL
to	NULL
interact	NULL
with	NULL
other	NULL
elements	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
p50	NULL
and	NULL
p65	NULL
have	NULL
different	NULL
affinities	NULL
for	NULL
specific	NULL
kB	NULL
motifs	NULL
,	NULL
implying	NULL
that	NULL
different	NULL
motifs	NULL
are	NULL
important	NULL
for	NULL
the	NULL
selective	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Neutrophils	NULL
(	NULL
polymorphonuclear	NULL
leukocytes	NULL
)	NULL
,	NULL
which	NULL
represent	NULL
70	NULL
%	NULL
of	NULL
circulating	NULL
leukocytes	NULL
,	NULL
are	NULL
terminally	NULL
differentiated	NULL
phagocytic	NULL
cells	NULL
.	NULL

The	NULL
body	NULL
's	NULL
first	NULL
line	NULL
of	NULL
defense	NULL
in	NULL
protecting	NULL
the	NULL
host	NULL
against	NULL
invading	NULL
microorganisms	NULL
,	NULL
neutrophils	NULL
also	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
immunologi-cally	NULL
induced	NULL
tissue	NULL
damage	NULL
.	NULL

Activated	NULL
neutrophils	NULL
can	NULL
perform	NULL
a	NULL
variety	NULL
of	NULL
specialized	NULL
cellular	NULL
functions	NULL
,	NULL
including	NULL
cellular	NULL
adhesion	NULL
,	NULL
aggregation	NULL
,	NULL
chemotaxis	NULL
,	NULL
phagocytosis	NULL
,	NULL
the	NULL
generation	NULL
of	NULL
reactive	NULL
oxygen	NULL
metabolites	NULL
,	NULL
and	NULL
the	NULL
secretion	NULL
of	NULL
enzymes	NULL
such	NULL
as	NULL
myeloperoxidase	NULL
and	NULL
lysozyme	NULL
,	NULL
which	NULL
are	NULL
located	NULL
in	NULL
granules	NULL
.	NULL
``	NULL

Within	NULL
minutes	NULL
of	NULL
stimulation	NULL
by	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
activators	NULL
and	NULL
chemotactic	NULL
factors	NULL
,	NULL
circulating	NULL
neutrophils	NULL
attach	NULL
to	NULL
the	NULL
endothelial	NULL
wall	NULL
of	NULL
the	NULL
blood	NULL
vessel	NULL
at	NULL
the	NULL
site	NULL
of	NULL
infection	NULL
.	NULL

Neutrophils	NULL
then	NULL
migrate	NULL
out	NULL
of	NULL
the	NULL
bloodstream	NULL
into	NULL
the	NULL
tissue	NULL
,	NULL
and	NULL
degranulate	NULL
readily	NULL
,	NULL
releasing	NULL
a	NULL
host	NULL
of	NULL
defensive	NULL
antimicrobial	NULL
prod-ucts	NULL
.	NULL
``	NULL

The	NULL
ability	NULL
of	NULL
neutrophils	NULL
to	NULL
attach	NULL
to	NULL
the	NULL
wall	NULL
of	NULL
the	NULL
blood	NULL
vessel	NULL
is	NULL
a	NULL
critical	NULL
component	NULL
of	NULL
the	NULL
host	NULL
defense	NULL
Blood	NULL
,	NULL
Vol	NULL
82	NULL
,	NULL
No	NULL
2	NULL
(	NULL
July	NULL
15	NULL
)	NULL
,	NULL
1993	NULL
:	NULL
pp	NULL
625-632	NULL
ferentiated	NULL
HL-60	NULL
leukemia	NULL
cells	NULL
stimulated	NULL
by	NULL
1	NULL
2-0-tetra-decanoylphorbol	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
.	NULL

These	NULL
effects	NULL
were	NULL
characterized	NULL
by	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
CD11b	NULL
integrin	NULL
expression	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
treated	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
effectively	NULL
abolished	NULL
an	NULL
upregulation	NULL
of	NULL
CD11b	NULL
that	NULL
was	NULL
produced	NULL
by	NULL
formyl-met-leu-phe	NULL
and	NULL
TPA	NULL
.	NULL

However	NULL
,	NULL
the	NULL
p65	NULL
antisense	NULL
phosphorothioate	NULL
oligodeoxynucleotide	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
the	NULL
production	NULL
of	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
or	NULL
on	NULL
phagocytosis	NULL
by	NULL
these	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
antisense	NULL
oligomers	NULL
to	NULL
p65	NULL
can	NULL
be	NULL
used	NULL
to	NULL
define	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
activation	NULL
pathways	NULL
of	NULL
neutrophils	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

mechanism	NULL
;	NULL
therefore	NULL
,	NULL
defects	NULL
in	NULL
neutrophil	NULL
adhesion	NULL
and	NULL
migration	NULL
can	NULL
lead	NULL
to	NULL
recurrent	NULL
,	NULL
life-threatening	NULL
infec-tions	NULL
.	NULL
``	NULL

Neutrophils	NULL
also	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
the	NULL
damage	NULL
to	NULL
host	NULL
tissue	NULL
that	NULL
occurs	NULL
in	NULL
disorders	NULL
such	NULL
as	NULL
rheuma-toid	NULL
arthritis	NULL
,	NULL
myocardial	NULL
reperfusion	NULL
damage	NULL
,	NULL
and	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Thus	NULL
,	NULL
novel	NULL
anti-inflam-matory	NULL
agents	NULL
able	NULL
to	NULL
block	NULL
neutrophil	NULL
activation	NULL
may	NULL
offer	NULL
therapeutic	NULL
benefits	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
conditions	NULL
in	NULL
which	NULL
an	NULL
unregulated	NULL
neutrophil	NULL
response	NULL
is	NULL
implicated	NULL
in	NULL
the	NULL
mechanism	NULL
of	NULL
tissue	NULL
destruction	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
elicit	NULL
differential	NULL
effects	NULL
on	NULL
cellular	NULL
adhesion	NULL
,	NULL
a	NULL
property	NULL
dependent	NULL
on	NULL
the	NULL
stage	NULL
of	NULL
differentiation	NULL
.	NULL
``	NULL

Because	NULL
several	NULL
cell	NULL
adhesion	NULL
molecules	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
,	NULL
'*	NULL
``	NULL
``	NULL
we	NULL
reasoned	NULL
that	NULL
the	NULL
antisense	NULL
oligomer-mediated	NULL
inhibition	NULL
of	NULL
cellular	NULL
adhesion	NULL
was	NULL
caused	NULL
by	NULL
inhibition	NULL
of	NULL
the	NULL
synthesis	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
adhesion	NULL
molecules	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
used	NULL
differentiated	NULL
HL-60	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
as	NULL
a	NULL
model	NULL
of	NULL
granulocytic	NULL
maturation	NULL
to	NULL
show	NULL
that	NULL
an	NULL
antisense	NULL
oligonucleotide	NULL
complementary	NULL
to	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
a	NULL
profound	NULL
effect	NULL
on	NULL
cell	NULL
attachment	NULL
and	NULL
on	NULL
the	NULL
production	NULL
of	NULL
important	NULL
cell	NULL
surface	NULL
adhesion	NULL
molecules	NULL
.	NULL

From	NULL
the	NULL
Department	NULL
of	NULL
Pharmacology	NULL
and	NULL
Developmental	NULL
Therapeutics	NULL
Program	NULL
,	NULL
Comprehensive	NULL
Cancer	NULL
Center	NULL
,	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
;	NULL
the	NULL
Department	NULL
of	NULL
Gene	NULL
Regu-lation	NULL
,	NULL
Roche	NULL
Institute	NULL
of	NULL
Molecular	NULL
Biology	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Oncology	NULL
,	NULL
Roche	NULL
Research	NULL
Center	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Inc	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
.	NULL

Submitted	NULL
December	NULL
2	NULL
,	NULL
1992	NULL
;	NULL
accepted	NULL
February	NULL
25	NULL
,	NULL
1993	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
US	NULL
Public	NULL
Health	NULL
Service	NULL
Grants	NULL
No	NULL
.	NULL

CA-02817	NULL
and	NULL
CA-16359	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Ramaswamy	NULL
Narayanan	NULL
,	NULL
PhD	NULL
,	NULL
Division	NULL
of	NULL
Oncology	NULL
,	NULL
Roche	NULL
Research	NULL
Center	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Inc	NULL
,	NULL
340	NULL
Kingsland	NULL
St	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
07110	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/93/8	NULL
202-001	NULL
5	NULL
$	NULL
3.00/0	NULL
625	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

626	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Antisense	NULL
oligonucleotides	NULL
.	NULL

-	NULL
The	NULL
antisense	NULL
and	NULL
sense	NULL
phosphorothioate	NULL
analogs	NULL
of	NULL
oligonucleotides	NULL
to	NULL
the	NULL
5	NULL
end	NULL
of	NULL
the	NULL
different	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
including	NULL
the	NULL
ATG	NULL
initiation	NULL
codon	NULL
(	NULL
21-24	NULL
mer	NULL
)	NULL
,	NULL
were	NULL
synthesized	NULL
using	NULL
an	NULL
automated	NULL
synthesizer	NULL
(	NULL
Model	NULL
394	NULL
;	NULL
Applied	NULL
Biosystems	NULL
,	NULL
Foster	NULL
City	NULL
,	NULL
CA	NULL
)	NULL
according	NULL
to	NULL
the	NULL
procedure	NULL
of	NULL
Matsukura	NULL
et	NULL
al	NULL
``	NULL
``	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Oligomers	NULL
were	NULL
purified	NULL
as	NULL
previously	NULL
described	NULL
``	NULL
with	NULL
the	NULL
modification	NULL
that	NULL
oligomers	NULL
were	NULL
routinely	NULL
re-extracted	NULL
six	NULL
times	NULL
with	NULL
ether	NULL
before	NULL
washing	NULL
with	NULL
absolute	NULL
ethanol	NULL
.	NULL

Stock	NULL
solutions	NULL
were	NULL
made	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
14	NULL
mg/mL	NULL
and	NULL
frozen	NULL
in	NULL
small	NULL
aliquots	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

-	NULL
HL-60	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
were	NULL
provided	NULL
by	NULL
Dr	NULL
Robert	NULL
C.	NULL
Gallo	NULL
(	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Be-thesda	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
routinely	NULL
propagated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
15	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

For	NULL
all	NULL
experiments	NULL
and	NULL
passages	NULL
,	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
5	NULL
to	NULL
10	NULL
x	NULL
10°	NULL
cells/	NULL
mL	NULL
and	NULL
incubated	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
-95	NULL
%	NULL
air	NULL
humidified	NULL
incubator	NULL
maintained	NULL
at	NULL
37°C	NULL
.	NULL

Passaged	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
exponential	NULL
growth	NULL
and	NULL
were	NULL
not	NULL
used	NULL
beyond	NULL
passage	NULL
60	NULL
.	NULL

Cell	NULL
numbers	NULL
were	NULL
measured	NULL
using	NULL
a	NULL
Coulter	NULL
ZBI	NULL
particle	NULL
counter	NULL
with	NULL
a	NULL
multichannel	NULL
analyzer	NULL
(	NULL
Coulter	NULL
Electronics	NULL
,	NULL
Hialeah	NULL
,	NULL
FL	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
routinely	NULL
screened	NULL
for	NULL
mycoplasma	NULL
infection	NULL
.	NULL

Granulocytic	NULL
-	NULL
maturation	NULL
.	NULL

-	NULL
Granulocytic	NULL
differentiation	NULL
-	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
cells	NULL
to	NULL
reduce	NULL
nitroblue	NULL
tetrazolium	NULL
.	NULL

After	NULL
induction	NULL
of	NULL
differentiation	NULL
by	NULL
exposure	NULL
to	NULL
1.3	NULL
%	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
for	NULL
7	NULL
days	NULL
,	NULL
aliquots	NULL
of	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
40	NULL
gmol/L	NULL
oligomer	NULL
and	NULL
placed	NULL
in	NULL
24-well	NULL
plates	NULL
for	NULL
various	NULL
periods	NULL
of	NULL
time	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
24-well	NULL
plates	NULL
to	NULL
minimize	NULL
the	NULL
consumption	NULL
of	NULL
oligodeoxynucleotides	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
phosphorothioates	NULL
were	NULL
added	NULL
to	NULL
cells	NULL
at	NULL
different	NULL
times	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
inducer	NULL
,	NULL
before	NULL
attainment	NULL
of	NULL
the	NULL
differentiated	NULL
pheno-type	NULL
.	NULL

Except	NULL
as	NULL
noted	NULL
,	NULL
all	NULL
experiments	NULL
were	NULL
repeated	NULL
at	NULL
least	NULL
four	NULL
times	NULL
with	NULL
independent	NULL
preparations	NULL
of	NULL
thiolated	NULL
oligomers	NULL
,	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
marker	NULL
of	NULL
mature	NULL
myeloid	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
antibody	NULL
for	NULL
30	NULL
minutes	NULL
on	NULL
ice	NULL
,	NULL
washed	NULL
with	NULL
PBS	NULL
,	NULL
and	NULL
fixed	NULL
in	NULL
PBS	NULL
containing	NULL
3.7	NULL
%	NULL
formaldehyde	NULL
;	NULL
CD1	NULL
1b	NULL
fluorescence	NULL
intensity	NULL
was	NULL
then	NULL
measured	NULL
using	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
production	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
was	NULL
measured	NULL
by	NULL
the	NULL
dichlorofluorescein	NULL
(	NULL
DCF	NULL
)	NULL
assay	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
phosphorothioate	NULL
for	NULL
6	NULL
hours	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
5	NULL
umol/L	NULL
dichlorofluorescein	NULL
diacetate	NULL
(	NULL
DCFH	NULL
,	NULL
-DA	NULL
;	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
for	NULL
1	NULL
5	NULL
minutes	NULL
,	NULL
followed	NULL
by	NULL
1	NULL
amol/L	NULL
12-0-tet-radecanoylphorbol	NULL
13-acetate	NULL
(	NULL
TPA	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
minutes	NULL
.	NULL

DCF	NULL
fluorescence	NULL
was	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
cells	NULL
to	NULL
phagocytize	NULL
beads	NULL
was	NULL
monitored	NULL
by	NULL
the	NULL
procedure	NULL
of	NULL
Blair	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Briefly	NULL
,	NULL
after	NULL
exposure	NULL
to	NULL
oligomers	NULL
for	NULL
6	NULL
Table	NULL
1	NULL
.	NULL

Phosphorothioate	NULL
Oligodeoxynucleotides	NULL
Used	NULL
in	NULL
These	NULL
Studies	NULL
Gene/Reference	NULL
No	NULL
.	NULL

Sequence	NULL
(	NULL
5	NULL
'	NULL
to	NULL
3	NULL
)	NULL
p65	NULL
sense	NULL
``	NULL
GCC	NULL
ATG	NULL
GAC	NULL
GAA	NULL
CTG	NULL
TTC	NULL
CCC	NULL
p65	NULL
antisense	NULL
``	NULL
GGG	NULL
GAA	NULL
CAG	NULL
TTC	NULL
GTC	NULL
CAT	NULL
GGC	NULL
p50	NULL
sense®	NULL
AGA	NULL
ATG	NULL
GCA	NULL
GAA	NULL
GAT	NULL
GAT	NULL
CCA	NULL
p50	NULL
antisense®	NULL
TGG	NULL
ATC	NULL
ATC	NULL
TTC	NULL
TGC	NULL
CAT	NULL
TCT	NULL
IkB	NULL
sense*	NULL
GCC	NULL
ATG	NULL
TTC	NULL
CAG	NULL
GCG	NULL
GCC	NULL
GAG	NULL
CGC	NULL
IkB	NULL
antisense®	NULL
GCG	NULL
CTC	NULL
GGC	NULL
CGC	NULL
CTG	NULL
GaA	NULL
CaT	NULL
GGC	NULL
The	NULL
oligonucleotide	NULL
sequence	NULL
corresponds	NULL
to	NULL
the	NULL
5	NULL
'	NULL
end	NULL
of	NULL
the	NULL
respective	NULL
mRNA	NULL
and	NULL
includes	NULL
three	NULL
nucleotides	NULL
present	NULL
upstream	NULL
of	NULL
the	NULL
initiation	NULL
codon	NULL
.	NULL

SOKOLOSKI	NULL
ET	NULL
AL	NULL
hours	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
to	NULL
2	NULL
X	NULL
10	NULL
``	NULL
fluorescent	NULL
micro-spheres	NULL
of	NULL
1.75	NULL
umol/L	NULL
diameter	NULL
(	NULL
Polysciences	NULL
,	NULL
Inc	NULL
,	NULL
Warrington	NULL
,	NULL
PA	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
8	NULL
hours	NULL
in	NULL
a	NULL
humidified	NULL
37°C	NULL
atmosphere	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
analyzed	NULL
using	NULL
a	NULL
flow	NULL
cytom-eter	NULL
;	NULL
the	NULL
percentage	NULL
of	NULL
cells	NULL
containing	NULL
FITC-microspheres	NULL
was	NULL
cal-culated	NULL
.	NULL

Polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
using	NULL
RNAzol-B	NULL
(	NULL
Cinna	NULL
Biotecx	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Semiquantitative	NULL
reverse	NULL
transcriptase-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
RNA	NULL
was	NULL
reverse	NULL
transcribed	NULL
into	NULL
cDNA	NULL
using	NULL
random	NULL
hexamers	NULL
.	NULL

One-tenth	NULL
of	NULL
the	NULL
cDNA	NULL
was	NULL
PCR	NULL
amplified	NULL
for	NULL
35	NULL
cycles	NULL
as	NULL
described	NULL
``	NULL
;	NULL
one-fifth	NULL
of	NULL
the	NULL
reaction	NULL
products	NULL
was	NULL
analyzed	NULL
by	NULL
3	NULL
%	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
bands	NULL
visualized	NULL
by	NULL
ethidium-bromide	NULL
staining	NULL
.	NULL

The	NULL
p65	NULL
primers	NULL
(	NULL
1	NULL
)	NULL
5	NULL
TCA	NULL
TCT	NULL
TCC	NULL
CGG	NULL
CAG	NULL
AGC	NULL
CAG	NULL
3	NULL
and	NULL
(	NULL
2	NULL
)	NULL
5	NULL
GTG	NULL
GGT	NULL
CTT	NULL
GGT	NULL
ATC	NULL
TGT	NULL
3	NULL
'	NULL
define	NULL
an	NULL
amplicon	NULL
of	NULL
150	NULL
bp	NULL
.	NULL

The	NULL
p50	NULL
primers	NULL
(	NULL
1	NULL
)	NULL
5	NULL
AAA	NULL
GGT	NULL
TAT	NULL
CGT	NULL
TCA	NULL
GTT	NULL
3	NULL
and	NULL
(	NULL
2	NULL
)	NULL
5	NULL
TTG	NULL
TAG	NULL
ATA	NULL
GGC	NULL
AAG	NULL
GTC	NULL
3	NULL
'	NULL
define	NULL
an	NULL
amplicon	NULL
of	NULL
250	NULL
bp	NULL
.	NULL

The	NULL
CD11b	NULL
primers	NULL
(	NULL
1	NULL
)	NULL
5	NULL
ATG	NULL
GCT	NULL
CTC	NULL
AGA	NULL
GTC	NULL
CTT	NULL
CTG	NULL
TAA	NULL
3	NULL
and	NULL
(	NULL
2	NULL
)	NULL
5	NULL
CAT	NULL
CAA	NULL
AGA	NULL
GAA	NULL
CAA	NULL
GGT	NULL
TTT	NULL
GGA	NULL
3	NULL
define	NULL
an	NULL
amplicon	NULL
of	NULL
522	NULL
bp	NULL
.	NULL

The	NULL
glyceraldehyde	NULL
phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
primers	NULL
have	NULL
been	NULL
described	NULL
.	NULL
``	NULL

RESULTS	NULL
In	NULL
a	NULL
previous	NULL
report	NULL
,	NULL
``	NULL
we	NULL
showed	NULL
that	NULL
antisense	NULL
oligonucleotides	NULL
complementary	NULL
to	NULL
p50	NULL
and	NULL
p65	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
had	NULL
differential	NULL
effects	NULL
on	NULL
the	NULL
adhesion	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
.	NULL

These	NULL
findings	NULL
suggested	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
,	NULL
either	NULL
as	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
,	NULL
are	NULL
capable	NULL
of	NULL
regulating	NULL
the	NULL
synthesis	NULL
of	NULL
integrin-like	NULL
molecules	NULL
in	NULL
cells	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
further	NULL
,	NULL
we	NULL
used	NULL
HL-60	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
as	NULL
a	NULL
model	NULL
of	NULL
granulocytic	NULL
differentiation	NULL
,	NULL
because	NULL
the	NULL
differentiation	NULL
of	NULL
these	NULL
cells	NULL
into	NULL
granulocyte-like	NULL
forms	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
development	NULL
of	NULL
a	NULL
complex	NULL
pattern	NULL
of	NULL
cellular	NULL
adhesion	NULL
that	NULL
is	NULL
modulated	NULL
by	NULL
changes	NULL
in	NULL
integrin	NULL
synthesis	NULL
.	NULL

Modified	NULL
phosphorothioate	NULL
oligonucleotides	NULL
to	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
the	NULL
inhibitory	NULL
IkB	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
were	NULL
synthesized	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Exposure	NULL
of	NULL
undifferentiated	NULL
HL-60	NULL
leukemia	NULL
cells	NULL
to	NULL
these	NULL
oligomers	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
cell	NULL
growth	NULL
or	NULL
differentiation	NULL
;	NULL
however	NULL
,	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
caused	NULL
a	NULL
marked	NULL
alteration	NULL
in	NULL
the	NULL
phenotype	NULL
of	NULL
HL-60	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
induced	NULL
by	NULL
DMSO	NULL
to	NULL
differentiate	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
TPA	NULL
,	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
did	NULL
not	NULL
attach	NULL
to	NULL
the	NULL
plastic	NULL
surface	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
but	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TPA	NULL
,	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
rapidly	NULL
adhered	NULL
to	NULL
the	NULL
plastic	NULL
dishes	NULL
in	NULL
a	NULL
process	NULL
that	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
marked	NULL
spreading	NULL
of	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

Exposure	NULL
of	NULL
p65	NULL
anti-sense-treated	NULL
cells	NULL
to	NULL
TPA	NULL
resulted	NULL
in	NULL
a	NULL
pronounced	NULL
alteration	NULL
of	NULL
these	NULL
adhesive	NULL
properties	NULL
(	NULL
Fig	NULL
1D	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cells	NULL
exposed	NULL
to	NULL
the	NULL
p65	NULL
oligomer	NULL
in	NULL
the	NULL
sense	NULL
configuration	NULL
(	NULL
Fig	NULL
1C	NULL
)	NULL
or	NULL
to	NULL
either	NULL
the	NULL
sense	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
or	NULL
antisense	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
configuration	NULL
of	NULL
p50	NULL
and	NULL
IkB	NULL
oligomers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
responded	NULL
to	NULL
TPA	NULL
treatment	NULL
in	NULL
a	NULL
manner	NULL
analogous	NULL
to	NULL
that	NULL
of	NULL
control	NULL
cells	NULL
not	NULL
exposed	NULL
to	NULL
a	NULL
phosphorothioate	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
oligomer	NULL
treatment	NULL
of	NULL
HL-60	NULL
cells	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
mRNA	NULL
was	NULL
measured	NULL
by	NULL
RT-PCR	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

The	NULL
p65	NULL
antisense	NULL
phosphorothioate	NULL
oligomer	NULL
abolished	NULL
p65	NULL
mRNA	NULL
expression	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
,	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
p50	NULL
or	NULL
of	NULL
GAPDH	NULL
,	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
AND	NULL
CELL	NULL
ADHESION	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
antisense	NULL
phosphorothioate	NULL
oligonucleotide	NULL
to	NULL
p65	NULL
on	NULL
the	NULL
spreading	NULL
of	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
after	NULL
treatment	NULL
with	NULL
TPA	NULL
.	NULL

HL-60	NULL
cells	NULL
that	NULL
acquired	NULL
a	NULL
differentiated	NULL
phenotype	NULL
after	NULL
exposure	NULL
to	NULL
DMSO	NULL
by	NULL
methodology	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
were	NULL
mixed	NULL
with	NULL
40	NULL
umol/L	NULL
of	NULL
oligomer	NULL
in	NULL
the	NULL
sense	NULL
and	NULL
antisense	NULL
configurations	NULL
(	NULL
oligomers	NULL
to	NULL
p50	NULL
and	NULL
to	NULL
p65	NULL
)	NULL
in	NULL
a	NULL
24-well	NULL
culture	NULL
dish	NULL
,	NULL
and	NULL
were	NULL
incubated	NULL
for	NULL
8	NULL
hours	NULL
.	NULL

Aliquots	NULL
were	NULL
removed	NULL
,	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
60	NULL
minutes	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug/ml	NULL
of	NULL
627	NULL
ANTISENSE	NULL
TPA	NULL
,	NULL
and	NULL
photographed	NULL
.	NULL

a	NULL
housekeeping	NULL
gene	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
p50	NULL
antisense	NULL
oligodeoxynucleotide	NULL
completely	NULL
abolished	NULL
p50	NULL
mRNA	NULL
expression	NULL
,	NULL
whereas	NULL
p65	NULL
and	NULL
GAPDH	NULL
mRNAs	NULL
were	NULL
not	NULL
affected	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
p65	NULL
antisense	NULL
oligonucleotide	NULL
on	NULL
cellular	NULL
aggregation	NULL
and	NULL
on	NULL
TPA-me-diated	NULL
adhesion	NULL
of	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
were	NULL
caused	NULL
by	NULL
the	NULL
selective	NULL
inhibition	NULL
of	NULL
p65	NULL
mRNA	NULL
expression	NULL
.	NULL

Addition-ally	NULL
,	NULL
the	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
effects	NULL
,	NULL
if	NULL
any	NULL
,	NULL
of	NULL
the	NULL
p50	NULL
antisense	NULL
molecule	NULL
in	NULL
granulocyte-like	NULL
HL-60	NULL
cells	NULL
remain	NULL
to	NULL
be	NULL
defined	NULL
.	NULL

Treatment	NULL
with	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
viability	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
as	NULL
ascertained	NULL
by	NULL
trypan	NULL
blue	NULL
exclu-sion	NULL
,	NULL
for	NULL
at	NULL
least	NULL
48	NULL
hours	NULL
after	NULL
exposure	NULL
,	NULL
or	NULL
alter	NULL
the	NULL
morphology	NULL
characteristic	NULL
of	NULL
differentiated	NULL
granulocytes	NULL
.	NULL

The	NULL
p65	NULL
phosphorothioate	NULL
oligomer	NULL
in	NULL
the	NULL
antisense	NULL
configuration	NULL
also	NULL
did	NULL
not	NULL
significantly	NULL
impair	NULL
the	NULL
ability	NULL
of	NULL
these	NULL
cells	NULL
to	NULL
phagocytize	NULL
latex	NULL
beads	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
or	NULL
to	NULL
produce	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
or	NULL
superoxide	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
were	NULL
transient	NULL
;	NULL
thus	NULL
,	NULL
when	NULL
cells	NULL
were	NULL
replated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
oligomer	NULL
for	NULL
4	NULL
hours	NULL
,	NULL
they	NULL
regained	NULL
the	NULL
capacity	NULL
to	NULL
spread	NULL
on	NULL
the	NULL
plastic	NULL
substratum	NULL
after	NULL
stimulation	NULL
of	NULL
attachment	NULL
by	NULL
TPA	NULL
.	NULL

These	NULL
findings	NULL
implied	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
p65	NULL
antisense	NULL
molecule	NULL
on	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
were	NULL
the	NULL
result	NULL
of	NULL
specific	NULL
alterations	NULL
in	NULL
cellular	NULL
adhesion	NULL
properties	NULL
and	NULL
not	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
toxicity	NULL
of	NULL
this	NULL
oligodeoxynucleotide	NULL
or	NULL
of	NULL
changes	NULL
in	NULL
the	NULL
differentiative	NULL
or	NULL
proliferative	NULL
status	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
changes	NULL
induced	NULL
by	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
in	NULL
the	NULL
adhesion	NULL
and	NULL
spreading	NULL
of	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
after	NULL
exposure	NULL
to	NULL
TPA	NULL
were	NULL
caused	NULL
by	NULL
alterations	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
integrin	NULL
molecules	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
we	NULL
monitored	NULL
the	NULL
effects	NULL
of	NULL
these	NULL
phosphoro-	NULL
thioates	NULL
on	NULL
expression	NULL
of	NULL
the	NULL
a2	NULL
subunit	NULL
of	NULL
integrin	NULL
(	NULL
CD11b/Mo	NULL
1	NULL
)	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
.	NULL

Exposure	NULL
to	NULL
the	NULL
p65	NULL
antisense	NULL
oligonucleotide	NULL
for	NULL
6	NULL
hours	NULL
caused	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

This	NULL
inhibitory	NULL
action	NULL
was	NULL
detectable	NULL
within	NULL
2	NULL
hours	NULL
and	NULL
was	NULL
retained	NULL
for	NULL
at	NULL
least	NULL
18	NULL
hours	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
exposure	NULL
to	NULL
the	NULL
p65	NULL
oligomer	NULL
in	NULL
the	NULL
sense	NULL
configuration	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
.	NULL

Furthermore	NULL
,	NULL
neither	NULL
p50	NULL
nor	NULL
IkB	NULL
antisense	NULL
molecules	NULL
,	NULL
or	NULL
their	NULL
respective	NULL
phosphorothioates	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
,	NULL
had	NULL
a	NULL
significant	NULL
effect	NULL
on	NULL
CD11b	NULL
integrin	NULL
expression	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
maintains	NULL
a	NULL
specific	NULL
function	NULL
in	NULL
granulocyte-like	NULL
cells	NULL
,	NULL
and	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1	NULL
b	NULL
and	NULL
possibly	NULL
that	NULL
of	NULL
other	NULL
mediators	NULL
of	NULL
cell	NULL
attachment	NULL
and	NULL
migration	NULL
.	NULL

Stimulation	NULL
of	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
by	NULL
the	NULL
chemotactic	NULL
factor	NULL
formyl-met-leu-phe	NULL
(	NULL
fMLP	NULL
)	NULL
or	NULL
by	NULL
TPA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
cause	NULL
an	NULL
upregulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
granulocytes	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
alters	NULL
this	NULL
process	NULL
,	NULL
we	NULL
exposed	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
treated	NULL
either	NULL
with	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
configuration	NULL
of	NULL
phosphorothioate	NULL
oligomers	NULL
to	NULL
fMLP	NULL
or	NULL
TPA	NULL
for	NULL
30	NULL
minutes	NULL
and	NULL
then	NULL
measured	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
exposure	NULL
to	NULL
fMLP	NULL
and	NULL
TPA	NULL
caused	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
,	NULL
presumably	NULL
representing	NULL
the	NULL
release	NULL
of	NULL
intracellular	NULL
stores	NULL
of	NULL
this	NULL
molecule	NULL
.	NULL

The	NULL
upregulation	NULL
of	NULL
CD1	NULL
1b	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
these	NULL
factors	NULL
produced	NULL
was	NULL
blocked	NULL
in	NULL
p65	NULL
anti-sense-treated	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
stimulation	NULL
of	NULL
CD11b	NULL
expression	NULL
by	NULL
fMLP	NULL
or	NULL
TPA	NULL
was	NULL
unaffected	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
the	NULL
p65	NULL
oligonucleotide	NULL
in	NULL
the	NULL
sense	NULL
configuration	NULL
.	NULL

Phosphorothioate	NULL
oligonucleotides	NULL
to	NULL
p50	NULL
and	NULL
IkB	NULL
in	NULL
either	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
form	NULL
also	NULL
did	NULL
not	NULL
significantly	NULL
alter	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

628	NULL
A	NULL
cas	NULL
&	NULL
«	NULL
*	NULL
606°	NULL
»	NULL
?	NULL

szva	NULL
P65	NULL
P50	NULL
GAPDH	NULL
B	NULL
s°	NULL
“	NULL
\®\	NULL
«	NULL
3°	NULL
Qﬁosxj	NULL
‘	NULL
k	NULL
'	NULL
ﬁ	NULL
P65	NULL
P50	NULL
GAPDH	NULL
Fig	NULL
2	NULL
.	NULL

Inhibition	NULL
of	NULL
p65	NULL
and	NULL
p50	NULL
mRNA	NULL
expression	NULL
by	NULL
antisense	NULL
oligomers	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
converted	NULL
to	NULL
a	NULL
differentiated	NULL
state	NULL
by	NULL
treatment	NULL
with	NULL
DMSO	NULL
for	NULL
7	NULL
days	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Cell	NULL
aliquots	NULL
(	NULL
5	NULL
mL	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
40	NULL
umol/L	NULL
phosphorothioate	NULL
oligonucleotides	NULL
to	NULL
p65	NULL
(	NULL
A	NULL
)	NULL
or	NULL
p50	NULL
(	NULL
B	NULL
)	NULL
in	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
configuration	NULL
in	NULL
a	NULL
6-well	NULL
tissue	NULL
culture	NULL
dish	NULL
,	NULL
incubated	NULL
for	NULL
8	NULL
hours	NULL
,	NULL
and	NULL
total	NULL
RNA	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
for	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
GAPDH	NULL
expression	NULL
.	NULL

CD1	NULL
1b	NULL
expression	NULL
after	NULL
exposure	NULL
to	NULL
TPA	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
p65	NULL
antisense	NULL
molecules	NULL
were	NULL
concentration	NULL
dependent	NULL
,	NULL
because	NULL
levels	NULL
of	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
lower	NULL
than	NULL
10	NULL
mol/L	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
stimulation	NULL
of	NULL
CD1	NULL
1b	NULL
expression	NULL
by	NULL
fMLP	NULL
,	NULL
whereas	NULL
concentrations	NULL
of	NULL
this	NULL
oligonucleotide	NULL
greater	NULL
than	NULL
20	NULL
amol/L	NULL
significantly	NULL
inhibited	NULL
CD1	NULL
1b	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
was	NULL
partially	NULL
restored	NULL
in	NULL
cells	NULL
washed	NULL
free	NULL
of	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
and	NULL
incubated	NULL
in	NULL
fresh	NULL
,	NULL
oligonucleotide-free	NULL
medium	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

We	NULL
next	NULL
investigated	NULL
whether	NULL
the	NULL
block	NULL
of	NULL
CD1	NULL
1b	NULL
expression	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
is	NULL
caused	NULL
by	NULL
inhibition	NULL
of	NULL
CD1	NULL
1b	NULL
mRNA	NULL
expression	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

The	NULL
control	NULL
HL-60	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
CD11b	NULL
mRNA	NULL
as	NULL
monitored	NULL
by	NULL
RT-PCR	NULL
.	NULL

The	NULL
DMSO-differentiated	NULL
HL-60	NULL
cells	NULL
showed	NULL
significant	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
mRNA	NULL
.	NULL

Treatment	NULL
of	NULL
DMSO-differentiated	NULL
HL-60	NULL
cells	NULL
with	NULL
either	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
p65	NULL
SOKOLOSKI	NULL
ET	NULL
AL	NULL
oligomers	NULL
did	NULL
not	NULL
inhibit	NULL
CD11b	NULL
mRNA	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
block	NULL
of	NULL
CD1	NULL
1b	NULL
surface	NULL
expression	NULL
is	NULL
not	NULL
caused	NULL
by	NULL
inhibition	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

DISCUSSION	NULL
The	NULL
studies	NULL
described	NULL
in	NULL
this	NULL
report	NULL
were	NULL
undertaken	NULL
to	NULL
gain	NULL
information	NULL
on	NULL
the	NULL
function	NULL
of	NULL
the	NULL
individual	NULL
subunits	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
complex	NULL
in	NULL
granulocytes	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
had	NULL
shown	NULL
that	NULL
antisense	NULL
oligodeoxynucleotides	NULL
to	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
had	NULL
differential	NULL
effects	NULL
on	NULL
adhesion	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
As	NULL
an	NULL
approach	NULL
to	NULL
investigate	NULL
this	NULL
phenomenon	NULL
further	NULL
,	NULL
we	NULL
used	NULL
HL-60	NULL
human	NULL
promyelocytic	NULL
leukemia	NULL
,	NULL
a	NULL
bipotential	NULL
cell	NULL
line	NULL
that	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
differentiate	NULL
into	NULL
both	NULL
granulocyte-like	NULL
and	NULL
monocyte-like	NULL
cells	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
chemical	NULL
agents	NULL
,	NULL
including	NULL
DMSO	NULL
.	NULL

Thus	NULL
,	NULL
HL-60	NULL
cells	NULL
offer	NULL
several	NULL
advantages	NULL
for	NULL
studies	NULL
on	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
on	NULL
cellular	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

80	NULL
7	NULL
201	NULL
%	NULL
Phagocytic	NULL
Cells	NULL
et	NULL
es	NULL
P50	NULL
AS	NULL
PSO	NULL
S	NULL
P65	NULL
AS	NULL
P6S	NULL
S	NULL
Relative	NULL
Fluorescence	NULL
Intensity	NULL
CONT	NULL
P50	NULL
S	NULL
PSO	NULL
AS	NULL
P6SS	NULL
P65	NULL
AS	NULL
IkBS	NULL
IkKB	NULL
AS	NULL
Fig	NULL
3	NULL
.	NULL

Effects	NULL
of	NULL
antisense	NULL
oligomers	NULL
to	NULL
p65	NULL
on	NULL
the	NULL
phagocytosis	NULL
and	NULL
production	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
by	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
converted	NULL
to	NULL
a	NULL
differentiated	NULL
state	NULL
by	NULL
treatment	NULL
with	NULL
DMSO	NULL
for	NULL
7	NULL
days	NULL
.	NULL

Cell	NULL
aliquots	NULL
were	NULL
incubated	NULL
with	NULL
40	NULL
umol/L	NULL
phosphorothioate	NULL
oligonucleotide	NULL
to	NULL
p65	NULL
in	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
configuration	NULL
for	NULL
6	NULL
hours	NULL
and	NULL
monitored	NULL
for	NULL
phagocytosis	NULL
(	NULL
A	NULL
)	NULL
and	NULL
the	NULL
production	NULL
of	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
B	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Hydrogen	NULL
peroxide	NULL
production	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
®	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
(	NULL
]	NULL
)	NULL
of	NULL
1.0	NULL
ug/ml	NULL
of	NULL
TPA	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
AND	NULL
CELL	NULL
ADHESION	NULL
1001	NULL
%	NULL
of	NULL
Control	NULL
Relative	NULL
Fluorescence	NULL
p50	NULL
S	NULL
p50	NULL
A	NULL
p65	NULL
S	NULL
p65	NULL
A	NULL
IkKB	NULL
S	NULL
IkB	NULL
A	NULL
Fig	NULL
4	NULL
.	NULL

Inhibition	NULL
of	NULL
CD11b	NULL
expression	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
by	NULL
phosphorothioate	NULL
antisense	NULL
oligomer	NULL
to	NULL
p-65	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
converted	NULL
to	NULL
a	NULL
differentiated	NULL
state	NULL
by	NULL
treatment	NULL
with	NULL
DMSO	NULL
for	NULL
7	NULL
days	NULL
.	NULL

Cell	NULL
aliquots	NULL
(	NULL
1	NULL
mL	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
40	NULL
umol/L	NULL
phosphorothioate	NULL
oligonucleotide	NULL
to	NULL
p65	NULL
in	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
configuration	NULL
in	NULL
a	NULL
24-well	NULL
tissue	NULL
culture	NULL
dish	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

Aliquots	NULL
were	NULL
removed	NULL
and	NULL
analyzed	NULL
for	NULL
CD11b	NULL
binding	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Neutrophils	NULL
attach	NULL
to	NULL
the	NULL
endothelial	NULL
cells	NULL
of	NULL
blood	NULL
vessels	NULL
before	NULL
leaving	NULL
the	NULL
bloodstream	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

The	NULL
extravasation	NULL
of	NULL
these	NULL
cells	NULL
requires	NULL
several	NULL
different	NULL
adhesion	NULL
proteins	NULL
that	NULL
function	NULL
in	NULL
a	NULL
multistep	NULL
adhesion	NULL
cas-cade	NULL
.	NULL

The	NULL
initial	NULL
events	NULL
occur	NULL
as	NULL
leukocytes	NULL
roll	NULL
along	NULL
the	NULL
vessel	NULL
wall	NULL
and	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
selectin	NULL
family	NULL
of	NULL
adhesion	NULL
receptors	NULL
.	NULL
``	NULL

''	NULL
Although	NULL
rolling	NULL
on	NULL
the	NULL
blood	NULL
vessel	NULL
wall	NULL
is	NULL
necessary	NULL
for	NULL
adhesion	NULL
,	NULL
it	NULL
is	NULL
not	NULL
by	NULL
itself	NULL
sufficient	NULL
.	NULL

These	NULL
adhesion	NULL
processes	NULL
require	NULL
the	NULL
presence	NULL
of	NULL
other	NULL
integrins	NULL
,	NULL
such	NULL
as	NULL
the	NULL
32	NULL
integrins	NULL
in	NULL
leukocytes	NULL
.	NULL
``	NULL

''	NULL
The	NULL
82	NULL
integrins	NULL
are	NULL
inactive	NULL
on	NULL
circulating	NULL
leukocytes	NULL
and	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
phorbol	NULL
esters	NULL
or	NULL
more	NULL
physiologically	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
inflammatory	NULL
stimuli	NULL
produced	NULL
by	NULL
the	NULL
endothelium	NULL
or	NULL
underlying	NULL
inflamed	NULL
tissue	NULL
,	NULL
such	NULL
as	NULL
chemotactic	NULL
peptides	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
CSa	NULL
,	NULL
or	NULL
platelet-activating	NULL
factor	NULL
.	NULL
``	NULL

''	NULL
Recently	NULL
,	NULL
it	NULL
has	NULL
become	NULL
evident	NULL
that	NULL
the	NULL
integrins	NULL
are	NULL
not	NULL
simply	NULL
adhesion	NULL
sites	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
but	NULL
may	NULL
modulate	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
processes	NULL
as	NULL
important	NULL
molecules	NULL
in	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
mediating	NULL
cellular	NULL
adhesion	NULL
and	NULL
motility	NULL
,	NULL
the	NULL
interactions	NULL
of	NULL
integrins	NULL
with	NULL
the	NULL
extracellular	NULL
matrix	NULL
proteins	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
a	NULL
number	NULL
of	NULL
other	NULL
important	NULL
cellular	NULL
processes	NULL
,	NULL
including	NULL
the	NULL
activation	NULL
and	NULL
gene	NULL
expression	NULL
of	NULL
fibroblasts	NULL
,	NULL
``	NULL
``	NULL
mono-cytes	NULL
,	NULL
``	NULL
and	NULL
T	NULL
lymphocytes	NULL
``	NULL
;	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
triggered	NULL
by	NULL
integrin	NULL
has	NULL
been	NULL
described	NULL
in	NULL
NIH	NULL
3T	NULL
3	NULL
cells	NULL
.	NULL
``	NULL

For	NULL
example	NULL
,	NULL
adherence	NULL
of	NULL
monocytes	NULL
to	NULL
the	NULL
extracellular	NULL
matrix	NULL
induces	NULL
genes	NULL
encoding	NULL
several	NULL
inflammation	NULL
media-tors	NULL
.	NULL
``	NULL

Adherence	NULL
of	NULL
neutrophils	NULL
through	NULL
3	NULL
integrins	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
costimulate	NULL
the	NULL
respiratory	NULL
burst	NULL
that	NULL
occurs	NULL
with	NULL
cytokines	NULL
.	NULL
``	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
integrins	NULL
may	NULL
be	NULL
part	NULL
of	NULL
the	NULL
signal	NULL
pathways	NULL
that	NULL
include	NULL
growth	NULL
factors	NULL
,	NULL
receptors	NULL
,	NULL
and	NULL
tyrosine	NULL
kinase	NULL
oncogene	NULL
products	NULL
.	NULL

They	NULL
also	NULL
suggest	NULL
a	NULL
mechanism	NULL
for	NULL
the	NULL
anchorage	NULL
depen-	NULL
629	NULL
dence	NULL
of	NULL
normal	NULL
growing	NULL
cells	NULL
and	NULL
its	NULL
loss	NULL
in	NULL
transformed	NULL
cells	NULL
.	NULL
``	NULL

Through	NULL
these	NULL
functions	NULL
the	NULL
integrins	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
both	NULL
development	NULL
and	NULL
the	NULL
adult	NULL
organ-ism	NULL
.	NULL

Although	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
can	NULL
form	NULL
heterodimers	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
these	NULL
molecules	NULL
may	NULL
also	NULL
function	NULL
as	NULL
homodimers	NULL
,	NULL
or	NULL
alternatively	NULL
,	NULL
as	NULL
heterodimers	NULL
with	NULL
other	NULL
proteins	NULL
that	NULL
are	NULL
presently	NULL
unknown	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
in	NULL
resting	NULL
cells	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
believed	NULL
to	NULL
exist	NULL
in	NULL
the	NULL
cytoplasm	NULL
as	NULL
an	NULL
inactive	NULL
complex	NULL
with	NULL
the	NULL
inhibitory	NULL
protein	NULL
IkB.3	NULL
'	NULL
We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
a	NULL
naturally	NULL
occurring	NULL
spliced	NULL
variant	NULL
of	NULL
p65	NULL
,	NULL
termed	NULL
p6SA	NULL
,	NULL
A	NULL
Relative	NULL
Fluorescence	NULL
Intensity	NULL
CONT	NULL
P5OS	NULL
P50	NULL
AS	NULL
P6SS	NULL
P65SAS	NULL
IkKBS	NULL
IkKB	NULL
AS	NULL
16	NULL
B	NULL
P	NULL
&	NULL
2	NULL
o	NULL
§	NULL
121	NULL
O	NULL
o	NULL
(	NULL
=	NULL
3	NULL
g	NULL
0.8	NULL
0	NULL
3	NULL
m	NULL
g	NULL
:	NULL
0.41	NULL
3	NULL
``	NULL
D	NULL
A	NULL
0.0	NULL
0	NULL
20	NULL
10	NULL
5.0	NULL
2.0	NULL
P65	NULL
(	NULL
uM	NULL
)	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
Inhibition	NULL
of	NULL
the	NULL
stimulation	NULL
of	NULL
CD11b	NULL
integrin	NULL
expression	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
by	NULL
antisense	NULL
oligonucleotides	NULL
to	NULL
NF-xB	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
converted	NULL
to	NULL
a	NULL
differentiated	NULL
state	NULL
by	NULL
treatment	NULL
with	NULL
DMSO	NULL
for	NULL
7	NULL
days	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cell	NULL
aliquots	NULL
(	NULL
1	NULL
mL	NULL
)	NULL
were	NULL
mixed	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
configuration	NULL
of	NULL
40	NULL
umol/L	NULL
oligonucleotides	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
a	NULL
24-well	NULL
culture	NULL
dish	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
8	NULL
hours	NULL
.	NULL

Aliquots	NULL
were	NULL
removed	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
minutes	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
®	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
C	NULL
)	NULL
of	NULL
10	NULL
umol/	NULL
L	NULL
fMLP	NULL
or	NULL
1	NULL
ug/ml	NULL
of	NULL
TPA	NULL
(	NULL
C	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cell	NULL
aliquots	NULL
(	NULL
1	NULL
mL	NULL
)	NULL
were	NULL
mixed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
40	NULL
umol/L	NULL
p65	NULL
antisense	NULL
oligodeoxynucleotide	NULL
in	NULL
a	NULL
24-well	NULL
culture	NULL
dish	NULL
and	NULL
incubated	NULL
for	NULL
8	NULL
hours	NULL
.	NULL

Aliquots	NULL
were	NULL
removed	NULL
and	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
minutes	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
C	NULL
)	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
(	NULL
]	NULL
)	NULL
of	NULL
10	NULL
«	NULL
mol/L	NULL
fMLP	NULL
.	NULL

Samples	NULL
were	NULL
washed	NULL
and	NULL
analyzed	NULL
for	NULL
CD11b	NULL
expression	NULL
by	NULL
flow	NULL
cytometry	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

630	NULL
which	NULL
lacks	NULL
a	NULL
functional	NULL
activation	NULL
domain	NULL
,	NULL
can	NULL
elicit	NULL
changes	NULL
in	NULL
cell	NULL
growth	NULL
and	NULL
cause	NULL
focus	NULL
formation	NULL
,	NULL
anchor-age-independent	NULL
growth	NULL
in	NULL
soft	NULL
agar	NULL
,	NULL
and	NULL
tumor	NULL
formation	NULL
in	NULL
athymic	NULL
nude	NULL
mice	NULL
.	NULL
``	NULL

In	NULL
our	NULL
most	NULL
recent	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
observed	NULL
that	NULL
inhibition	NULL
of	NULL
p65	NULL
expression	NULL
in	NULL
diverse	NULL
tumor-derived	NULL
cell	NULL
lines	NULL
by	NULL
p65	NULL
antisense	NULL
oligomers	NULL
blocks	NULL
cell	NULL
adhesion	NULL
in	NULL
vitro	NULL
and	NULL
growth	NULL
in	NULL
vivo	NULL
.	NULL
``	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
p65	NULL
may	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
a	NULL
set	NULL
of	NULL
genes	NULL
essential	NULL
for	NULL
transformation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
reduced	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
would	NULL
prevent	NULL
the	NULL
attachment	NULL
of	NULL
neutrophils	NULL
,	NULL
we	NULL
incubated	NULL
HL-60	NULL
cells	NULL
in	NULL
DMSO	NULL
under	NULL
conditions	NULL
that	NULL
caused	NULL
them	NULL
to	NULL
terminally	NULL
differentiate	NULL
,	NULL
and	NULL
then	NULL
treated	NULL
these	NULL
cells	NULL
with	NULL
antisense	NULL
oligonucleotides	NULL
of	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
IkB	NULL
.	NULL

The	NULL
treatment	NULL
of	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
with	NULL
an	NULL
oligodeoxynucleotide	NULL
antisense	NULL
to	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
cell	NULL
spreading	NULL
that	NULL
followed	NULL
a	NULL
short	NULL
period	NULL
of	NULL
exposure	NULL
to	NULL
TPA	NULL
.	NULL

Treatment	NULL
of	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
with	NULL
the	NULL
p65	NULL
antisense	NULL
oligomer	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
reduction	NULL
in	NULL
the	NULL
level	NULL
of	NULL
the	NULL
CD11b	NULL
marker	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
which	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
pronounced	NULL
inhibition	NULL
of	NULL
the	NULL
recruitment	NULL
of	NULL
additional	NULL
CD1	NULL
1b	NULL
molecules	NULL
to	NULL
the	NULL
surface	NULL
from	NULL
stored	NULL
vesicles	NULL
on	NULL
stimulation	NULL
of	NULL
these	NULL
cells	NULL
by	NULL
fMLP	NULL
or	NULL
TPA	NULL
.	NULL

These	NULL
effects	NULL
occurred	NULL
within	NULL
2	NULL
hours	NULL
and	NULL
depended	NULL
on	NULL
the	NULL
state	NULL
of	NULL
differentiation	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
because	NULL
undifferentiated	NULL
HL-60	NULL
cells	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
p65	NULL
antisense	NULL
oligonucleotide	NULL
.	NULL

Differentiated	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
p65	NULL
antisense	NULL
molecules	NULL
were	NULL
viable	NULL
and	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
respond	NULL
to	NULL
treatment	NULL
with	NULL
TPA	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
free	NULL
of	NULL
the	NULL
oligomer	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
cells	NULL
to	NULL
undergo	NULL
phagocytosis	NULL
and	NULL
produce	NULL
superoxide	NULL
and	NULL
hydrogen	NULL
peroxide	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
treatment	NULL
with	NULL
the	NULL
p65	NULL
phosphorothioate	NULL
in	NULL
the	NULL
antisense	NULL
configuration	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
these	NULL
phenotypic	NULL
markers	NULL
of	NULL
the	NULL
differentiated	NULL
granulocyte	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
and	NULL
TPA-induced	NULL
cell	NULL
spreading	NULL
after	NULL
attachment	NULL
are	NULL
under	NULL
separate	NULL
genomic	NULL
control	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
earlier	NULL
find-ings	NULL
,	NULL
``	NULL
*	NULL
``	NULL
>	NULL
we	NULL
observed	NULL
no	NULL
expression	NULL
of	NULL
CD1	NULL
1b	NULL
mRNA	NULL
in	NULL
the	NULL
undifferentiated	NULL
HL-60	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
exposed	NULL
to	NULL
p65	NULL
antisense	NULL
oligomers	NULL
showed	NULL
no	NULL
inhibition	NULL
of	NULL
CD1	NULL
1b	NULL
mRNA	NULL
expression	NULL
.	NULL

This	NULL
is	NULL
not	NULL
surprising	NULL
,	NULL
CD	NULL
11b	NULL
GAPDH	NULL
SOKOLOSKI	NULL
ET	NULL
AL	NULL
Fig	NULL
6	NULL
.	NULL

Lack	NULL
of	NULL
inhibition	NULL
of	NULL
CD11b	NULL
mRNA	NULL
expression	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
by	NULL
p65	NULL
antisense	NULL
oligomer	NULL
.	NULL

HL-60	NULL
cells	NULL
were	NULL
converted	NULL
to	NULL
a	NULL
differentiated	NULL
state	NULL
by	NULL
treatment	NULL
with	NULL
DMSO	NULL
for	NULL
7	NULL
days	NULL
.	NULL

Cell	NULL
aliquots	NULL
(	NULL
5	NULL
mL	NULL
)	NULL
were	NULL
mixed	NULL
with	NULL
40	NULL
umol/L	NULL
phosphorothioate	NULL
oligonucleotides	NULL
to	NULL
p65	NULL
sense	NULL
or	NULL
antisense	NULL
oligomers	NULL
for	NULL
48	NULL
hours	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
analyzed	NULL
by	NULL
semiquantitative	NULL
RT-PCR	NULL
for	NULL
CD11b	NULL
and	NULL
GAPDH	NULL
expression	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
control	NULL
HL-60	NULL
cells	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
7-day	NULL
DMSO-differentiated	NULL
HL-60	NULL
cells	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
,	NULL
DMSO-differentiated	NULL
HL-60	NULL
cells	NULL
treated	NULL
with	NULL
sense	NULL
p65	NULL
and	NULL
antisense	NULL
p65	NULL
oligomers	NULL
,	NULL
respectively	NULL
;	NULL
and	NULL
lane	NULL
5	NULL
,	NULL
template	NULL
minus	NULL
control	NULL
.	NULL

because	NULL
the	NULL
CD1	NULL
1b	NULL
promoter	NULL
sequence	NULL
does	NULL
not	NULL
encode	NULL
the	NULL
putative	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
.	NULL
``	NULL

''	NULL
These	NULL
results	NULL
suggest	NULL
that	NULL
p65	NULL
antisense	NULL
oligomers	NULL
may	NULL
be	NULL
blocking	NULL
transcription	NULL
of	NULL
some	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
important	NULL
for	NULL
the	NULL
release	NULL
of	NULL
intracellular	NULL
granules	NULL
containing	NULL
preformed	NULL
CD1	NULL
1b	NULL
.	NULL

Alternatively	NULL
,	NULL
p65	NULL
antisense	NULL
oligomers	NULL
may	NULL
be	NULL
affecting	NULL
the	NULL
release	NULL
of	NULL
CD1	NULL
1b	NULL
from	NULL
the	NULL
granules	NULL
by	NULL
nontranscriptional	NULL
mechanisms	NULL
.	NULL

Interference	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
p50	NULL
mRNA	NULL
by	NULL
the	NULL
p50	NULL
antisense	NULL
oligomer	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
cellular	NULL
attachment	NULL
or	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
CD11b	NULL
.	NULL

At	NULL
present	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
why	NULL
the	NULL
decrease	NULL
in	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
p50	NULL
mRNA	NULL
did	NULL
not	NULL
result	NULL
in	NULL
any	NULL
measurable	NULL
effects	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
p65	NULL
may	NULL
function	NULL
with	NULL
some	NULL
additional	NULL
unknown	NULL
factor	NULL
of	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
complex	NULL
as	NULL
a	NULL
heterodimer	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
or	NULL
that	NULL
p50	NULL
may	NULL
possibly	NULL
behave	NULL
as	NULL
a	NULL
homodimer	NULL
.	NULL

Because	NULL
we	NULL
were	NULL
able	NULL
to	NULL
observe	NULL
the	NULL
presence	NULL
of	NULL
p50	NULL
mRNA	NULL
in	NULL
differentiated	NULL
HL-60	NULL
cells	NULL
and	NULL
show	NULL
the	NULL
subsequent	NULL
inhibition	NULL
of	NULL
its	NULL
expression	NULL
by	NULL
treatment	NULL
of	NULL
these	NULL
cells	NULL
with	NULL
a	NULL
p50	NULL
antisense	NULL
oligomer	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
p50	NULL
may	NULL
regulate	NULL
functions	NULL
not	NULL
yet	NULL
known	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
cell	NULL
attachment	NULL
in	NULL
granulocytes	NULL
,	NULL
possibly	NULL
through	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
or	NULL
other	NULL
growth	NULL
factors	NULL
.	NULL

As	NULL
our	NULL
studies	NULL
used	NULL
cellular	NULL
adhesion	NULL
to	NULL
a	NULL
plastic	NULL
surface	NULL
as	NULL
a	NULL
model	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
,	NULL
we	NULL
can	NULL
not	NULL
provide	NULL
evidence	NULL
that	NULL
supports	NULL
other	NULL
possible	NULL
functions	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

An	NULL
obvious	NULL
question	NULL
that	NULL
arises	NULL
from	NULL
these	NULL
studies	NULL
is	NULL
how	NULL
antisense	NULL
oligomers	NULL
to	NULL
p65	NULL
regulate	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Does	NULL
the	NULL
loss	NULL
of	NULL
p65	NULL
have	NULL
a	NULL
direct	NULL
inhibitory	NULL
role	NULL
on	NULL
the	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
promoting	NULL
gene	NULL
expression	NULL
,	NULL
or	NULL
alternatively	NULL
,	NULL
does	NULL
the	NULL
loss	NULL
of	NULL
p65	NULL
indirectly	NULL
result	NULL
in	NULL
the	NULL
imbalancing	NULL
of	NULL
some	NULL
other	NULL
yet	NULL
undefined	NULL
factor	NULL
?	NULL

We	NULL
speculate	NULL
that	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
p65	NULL
may	NULL
disrupt	NULL
the	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
inhibiting	NULL
the	NULL
induction	NULL
of	NULL
subtle	NULL
changes	NULL
in	NULL
the	NULL
ratio	NULL
of	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
that	NULL
are	NULL
essential	NULL
for	NULL
normal	NULL
cellular	NULL
function	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
p65	NULL
may	NULL
affect	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
transcription	NULL
by	NULL
a	NULL
p65	NULL
homodimeric	NULL
complex	NULL
,	NULL
or	NULL
may	NULL
act	NULL
indirectly	NULL
by	NULL
limiting	NULL
the	NULL
availability	NULL
of	NULL
p65	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
p65-p50	NULL
het-erodimeric	NULL
complexes	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
seems	NULL
to	NULL
act	NULL
as	NULL
a	NULL
regulator	NULL
that	NULL
funnels	NULL
diverse	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
AND	NULL
CELL	NULL
ADHESION	NULL
intracellular	NULL
signals	NULL
through	NULL
a	NULL
single	NULL
protein	NULL
complex	NULL
to	NULL
the	NULL
DNA	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
triggers	NULL
a	NULL
unified	NULL
response	NULL
.	NULL
``	NULL

''	NULL
Diverse	NULL
agents	NULL
seem	NULL
to	NULL
communicate	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
through	NULL
membrane	NULL
receptors	NULL
and	NULL
second	NULL
messenger	NULL
systems	NULL
activated	NULL
by	NULL
these	NULL
receptors	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
there	NULL
are	NULL
many	NULL
inducible	NULL
genes	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
motifs	NULL
wherein	NULL
the	NULL
factor	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

One	NULL
common	NULL
denominator	NULL
of	NULL
NF-	NULL
«	NULL
xB-controlled	NULL
genes	NULL
is	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
encoded	NULL
genes	NULL
in	NULL
inflammatory	NULL
and	NULL
other	NULL
acute-phase	NULL
responses	NULL
.	NULL
``	NULL

Many	NULL
if	NULL
not	NULL
all	NULL
of	NULL
the	NULL
target	NULL
genes	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
encode	NULL
for	NULL
immunoreceptor	NULL
molecules	NULL
,	NULL
such	NULL
as	NULL
the	NULL
integrins	NULL
,	NULL
cytokines	NULL
,	NULL
and	NULL
other	NULL
acute-phase	NULL
proteins	NULL
.	NULL

Thus	NULL
,	NULL
induction	NULL
of	NULL
these	NULL
many	NULL
specialized	NULL
proteins	NULL
by	NULL
NF-xB	NULL
may	NULL
constitute	NULL
a	NULL
set	NULL
of	NULL
cellular	NULL
responses	NULL
to	NULL
pathogenic	NULL
signals	NULL
or	NULL
injuries	NULL
that	NULL
result	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
encoding	NULL
defense	NULL
proteins	NULL
.	NULL
``	NULL

Another	NULL
characteristic	NULL
common	NULL
to	NULL
these	NULL
target	NULL
genes	NULL
is	NULL
their	NULL
rapid	NULL
induc-tion	NULL
,	NULL
evidenced	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
cytoplasmic	NULL
precursors	NULL
of	NULL
the	NULL
activating	NULL
complex	NULL
,	NULL
its	NULL
simple	NULL
dissociation	NULL
from	NULL
the	NULL
inactive	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
lack	NULL
of	NULL
requirement	NULL
for	NULL
new	NULL
protein	NULL
synthesis	NULL
.	NULL

The	NULL
findings	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
identify	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
as	NULL
a	NULL
key	NULL
component	NULL
in	NULL
the	NULL
activation	NULL
pathway	NULL
of	NULL
neutrophils	NULL
stimulated	NULL
by	NULL
fMLP	NULL
and	NULL
TPA	NULL
,	NULL
and	NULL
provide	NULL
evidence	NULL
to	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
important	NULL
element	NULL
in	NULL
the	NULL
production	NULL
of	NULL
cellular	NULL
molecules	NULL
essential	NULL
for	NULL
the	NULL
host	NULL
defense	NULL
mechanism	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
W.	NULL
McComas	NULL
for	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
phosphorothioate	NULL
oligonucleotides	NULL
,	NULL
R.	NULL
Carbone	NULL
for	NULL
his	NULL
assistance	NULL
with	NULL
the	NULL
flow	NULL
cytometric	NULL
analyses	NULL
,	NULL
K.	NULL
Dorshkind	NULL
for	NULL
a	NULL
critical	NULL
review	NULL
,	NULL
K.	NULL
Higgins	NULL
for	NULL
excellent	NULL
technical	NULL
support	NULL
,	NULL
and	NULL
J.	NULL
Narayanan	NULL
for	NULL
editorial	NULL
assistance	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Nabel	NULL
G	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
An	NULL
inducible	NULL
transcriptional	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
335:683	NULL
,	NULL
1987	NULL
2	NULL
.	NULL

Baeuerle	NULL
PA	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
The	NULL
physiology	NULL
of	NULL
the	NULL
NF-kappa-B	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
Aspects	NULL
Cell	NULL
Regul	NULL
6:409	NULL
,	NULL
1991	NULL
3	NULL
.	NULL

Lenardo	NULL
MJ	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
A	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227	NULL
,	NULL
1989	NULL
4	NULL
.	NULL

Nolan	NULL
GP	NULL
,	NULL
Ghosh	NULL
S	NULL
,	NULL
Liou	NULL
HC	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
DNA	NULL
binding	NULL
and	NULL
I	NULL
«	NULL
B	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
rel	NULL
related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961	NULL
,	NULL
1991	NULL
5	NULL
.	NULL

Ruben	NULL
SM	NULL
,	NULL
Dillon	NULL
PJ	NULL
,	NULL
Schreck	NULL
R	NULL
,	NULL
Henkel	NULL
T	NULL
,	NULL
Chen	NULL
CH	NULL
,	NULL
Maher	NULL
M	NULL
,	NULL
Bacuerle	NULL
PA	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
251:1490	NULL
,	NULL
1991	NULL
6	NULL
.	NULL

Ghosh	NULL
S	NULL
,	NULL
Gifford	NULL
AM	NULL
,	NULL
Riviere	NULL
LB	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Nolan	NULL
GP	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
Homology	NULL
to	NULL
rel	NULL
and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019	NULL
,	NULL
1990	NULL
7	NULL
.	NULL

Kieran	NULL
M	NULL
,	NULL
Blank	NULL
V	NULL
,	NULL
Longeat	NULL
F	NULL
,	NULL
Vanderkerchove	NULL
J	NULL
,	NULL
Lottspeich	NULL
F	NULL
,	NULL
LeBail	NULL
O0	NULL
,	NULL
Urban	NULL
MB	NULL
,	NULL
Kourilsky	NULL
P	NULL
,	NULL
Baeuerle	NULL
PA	NULL
,	NULL
Israel	NULL
A	NULL
:	NULL
The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBFI1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
rel	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007	NULL
,	NULL
1990	NULL
8	NULL
.	NULL

Rice	NULL
NR	NULL
,	NULL
Gilden	NULL
RV	NULL
:	NULL
The	NULL
rel	NULL
oncogene	NULL
,	NULL
in	NULL
Reddy	NULL
EP	NULL
,	NULL
Skalka	NULL
AM	NULL
,	NULL
Curran	NULL
T	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
The	NULL
Oncogene	NULL
Handbook	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Elsevier	NULL
,	NULL
1988	NULL
,	NULL
p	NULL
495	NULL
9	NULL
.	NULL

Steward	NULL
R	NULL
:	NULL
Dorsal	NULL
,	NULL
an	NULL
embryonic	NULL
polarity	NULL
gene	NULL
in	NULL
drosophila	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
vertebrate	NULL
proto-oncogene	NULL
,	NULL
c-rel	NULL
.	NULL

Science	NULL
238:692	NULL
,	NULL
1987	NULL
631	NULL
10	NULL
.	NULL

Ruben	NULL
SM	NULL
,	NULL
Narayanan	NULL
R	NULL
,	NULL
Klement	NULL
JF	NULL
,	NULL
Chen	NULL
CH	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
derivative	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
12:444	NULL
,	NULL
1992	NULL
11	NULL
.	NULL

Goldstein	NULL
IM	NULL
:	NULL
Contemporary	NULL
Topics	NULL
in	NULL
Immunobiology	NULL
.	NULL

New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
Plenum	NULL
,	NULL
1984	NULL
12	NULL
.	NULL

Baggioni	NULL
M	NULL
:	NULL
Handbook	NULL
of	NULL
Inflammation	NULL
.	NULL

Amsterdam	NULL
,	NULL
The	NULL
Netherlands	NULL
,	NULL
Elsevier	NULL
,	NULL
1980	NULL
13	NULL
.	NULL

Osborn	NULL
L	NULL
:	NULL
Leukocyte	NULL
adhesion	NULL
to	NULL
endothelium	NULL
in	NULL
inflammation	NULL
.	NULL

Cell	NULL
62:3	NULL
,	NULL
1990	NULL
14	NULL
.	NULL

Henson	NULL
PM	NULL
,	NULL
Johnston	NULL
RB	NULL
:	NULL
Tissue	NULL
injury	NULL
in	NULL
inflammation	NULL
.	NULL

Oxidant	NULL
,	NULL
proteases	NULL
and	NULL
cationic	NULL
proteins	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
79:669	NULL
,	NULL
1987	NULL
15	NULL
.	NULL

Malech	NULL
HL	NULL
,	NULL
Gallin	NULL
J	NULL
:	NULL
Neutrophils	NULL
in	NULL
human	NULL
disease	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
317:687	NULL
,	NULL
1987	NULL
16	NULL
.	NULL

Weiss	NULL
SJ	NULL
:	NULL
Tissue	NULL
destruction	NULL
by	NULL
neutrophils	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
320:365	NULL
,	NULL
1989	NULL
17	NULL
.	NULL

Narayanan	NULL
R	NULL
,	NULL
Higgins	NULL
KA	NULL
,	NULL
Coleman	NULL
TA	NULL
,	NULL
Lawlor	NULL
KG	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Evidence	NULL
for	NULL
differential	NULL
functions	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
p65	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
using	NULL
a	NULL
cell	NULL
adhesion	NULL
model	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
(	NULL
in	NULL
press	NULL
)	NULL
18	NULL
.	NULL

Lilienbaum	NULL
A	NULL
,	NULL
Duc	NULL
Dodon	NULL
M	NULL
,	NULL
Alexandre	NULL
C	NULL
,	NULL
Gazzolo	NULL
L	NULL
,	NULL
Paulin	NULL
D	NULL
:	NULL
Effect	NULL
of	NULL
human	NULL
T-cell	NULL
virus	NULL
type	NULL
I	NULL
TAX	NULL
protein	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
vimentin	NULL
gene	NULL
.	NULL

J	NULL
Virol	NULL
64:256	NULL
,	NULL
1990	NULL
19	NULL
.	NULL

Whelan	NULL
J	NULL
,	NULL
Ghersa	NULL
P	NULL
,	NULL
van	NULL
Huijsduijnen	NULL
RH	NULL
,	NULL
Gray	NULL
J	NULL
,	NULL
Chandra	NULL
G	NULL
,	NULL
Talabot	NULL
F	NULL
,	NULL
DeLamorter	NULL
JF	NULL
:	NULL
An	NULL
NF-	NULL
«	NULL
B	NULL
like	NULL
factor	NULL
is	NULL
essential	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
cytokine	NULL
induction	NULL
of	NULL
endothelial	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
I	NULL
(	NULL
ELAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
19:2645	NULL
,	NULL
1991	NULL
20	NULL
.	NULL

Voraberger	NULL
G	NULL
,	NULL
Schafer	NULL
R	NULL
,	NULL
Stratowa	NULL
C	NULL
:	NULL
Cloning	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
for	NULL
intracellular	NULL
adhesion	NULL
molecule	NULL
I	NULL
and	NULL
analysis	NULL
of	NULL
its	NULL
5	NULL
regulatory	NULL
region	NULL
:	NULL
Induction	NULL
by	NULL
cytokines	NULL
and	NULL
phorbol	NULL
ester	NULL
.	NULL

J	NULL
Immunol	NULL
147:2777	NULL
,	NULL
1991	NULL
21	NULL
.	NULL

Matsukura	NULL
M	NULL
,	NULL
Shinozuka	NULL
K	NULL
,	NULL
Zon	NULL
G	NULL
,	NULL
Mitsuya	NULL
H	NULL
,	NULL
Reitz	NULL
M	NULL
,	NULL
Cohen	NULL
JS	NULL
,	NULL
Broder	NULL
S	NULL
:	NULL
Phosphothioate	NULL
analogs	NULL
of	NULL
oligodeoxynucleo-tides	NULL
:	NULL
Inhibitors	NULL
of	NULL
replication	NULL
and	NULL
cytopathic	NULL
effects	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
84:7706	NULL
,	NULL
1987	NULL
22	NULL
.	NULL

Narayanan	NULL
R	NULL
,	NULL
Lawlor	NULL
KG	NULL
,	NULL
Schaapveld	NULL
RQJ	NULL
,	NULL
Cho	NULL
KR	NULL
,	NULL
Vo-gelstein	NULL
B	NULL
,	NULL
Tran	NULL
PBV	NULL
,	NULL
Osborne	NULL
MP	NULL
,	NULL
Telang	NULL
NT	NULL
:	NULL
Antisense	NULL
RNA	NULL
to	NULL
the	NULL
putative	NULL
tumor-suppressor	NULL
gene	NULL
DCC	NULL
transforms	NULL
rat-1	NULL
fibro-blasts	NULL
.	NULL

Oncogene	NULL
7:553	NULL
,	NULL
1992	NULL
23	NULL
.	NULL

Bass	NULL
DA	NULL
,	NULL
Pearse	NULL
JW	NULL
,	NULL
Dechatelet	NULL
LR	NULL
,	NULL
Szeda	NULL
P	NULL
,	NULL
Seeds	NULL
M	NULL
,	NULL
Thomas	NULL
M	NULL
:	NULL
Flow	NULL
cytometric	NULL
studies	NULL
of	NULL
oxidative	NULL
product	NULL
formation	NULL
by	NULL
neutrophils	NULL
:	NULL
A	NULL
graded	NULL
response	NULL
to	NULL
membrane	NULL
stimulation	NULL
.	NULL

J	NULL
Immunol	NULL
130:1910	NULL
,	NULL
1983	NULL
24	NULL
.	NULL

Blair	NULL
OC	NULL
,	NULL
Carbone	NULL
R	NULL
,	NULL
Sartorelli	NULL
AC	NULL
:	NULL
Differentiation	NULL
of	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
:	NULL
Simultaneous	NULL
determination	NULL
of	NULL
phagocytic	NULL
activity	NULL
and	NULL
cell	NULL
cycle	NULL
distribution	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Cytometry	NULL
7:171	NULL
,	NULL
1986	NULL
25	NULL
.	NULL

Lawrence	NULL
MB	NULL
,	NULL
Springer	NULL
TA	NULL
:	NULL
Leukocytes	NULL
roll	NULL
on	NULL
a	NULL
selection	NULL
at	NULL
physiological	NULL
flow	NULL
rates	NULL
:	NULL
Distinction	NULL
from	NULL
and	NULL
prerequisite	NULL
for	NULL
adhesion	NULL
through	NULL
integrins	NULL
.	NULL

Cell	NULL
65:859	NULL
,	NULL
1991	NULL
26	NULL
.	NULL

Werb	NULL
Z	NULL
,	NULL
Tremble	NULL
PM	NULL
,	NULL
Behrendtsen	NULL
O	NULL
,	NULL
Crowley	NULL
E	NULL
,	NULL
Damsky	NULL
CH	NULL
:	NULL
Signal	NULL
transduction	NULL
through	NULL
the	NULL
fibronectin	NULL
receptor	NULL
induces	NULL
collagenase	NULL
and	NULL
stromelysin	NULL
gene	NULL
expression	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
109:877	NULL
,	NULL
1989	NULL
27	NULL
.	NULL

Sporn	NULL
SA	NULL
,	NULL
Eierman	NULL
DF	NULL
,	NULL
Johnson	NULL
CE	NULL
,	NULL
Morris	NULL
J	NULL
,	NULL
Martin	NULL
G	NULL
,	NULL
Ladner	NULL
M	NULL
,	NULL
Haskill	NULL
S	NULL
:	NULL
Monocyte	NULL
adherence	NULL
results	NULL
in	NULL
selective	NULL
induction	NULL
of	NULL
novel	NULL
genes	NULL
sharing	NULL
homology	NULL
with	NULL
mediators	NULL
of	NULL
inflammation	NULL
and	NULL
tissue	NULL
repair	NULL
.	NULL

J	NULL
Immunol	NULL
144:4434	NULL
,	NULL
1990	NULL
28	NULL
.	NULL

Shimizu	NULL
Y	NULL
,	NULL
VanSeventer	NULL
GA	NULL
,	NULL
Horgan	NULL
KJ	NULL
,	NULL
Shaw	NULL
S	NULL
:	NULL
Regulated	NULL
expression	NULL
and	NULL
binding	NULL
of	NULL
three	NULL
VLA	NULL
(	NULL
B1	NULL
)	NULL
integrin	NULL
receptors	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
345:250	NULL
,	NULL
1990	NULL
29	NULL
.	NULL

Guan	NULL
JL	NULL
,	NULL
Trevithick	NULL
JE	NULL
,	NULL
Hynes	NULL
RO	NULL
:	NULL
Fibronectin/integrin	NULL
interaction	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
120	NULL
kDa	NULL
protein	NULL
.	NULL

Cell	NULL
Regul	NULL
2:951	NULL
,	NULL
1991	NULL
30	NULL
.	NULL

Nathan	NULL
C	NULL
,	NULL
Srimal	NULL
S	NULL
,	NULL
Farber	NULL
C	NULL
,	NULL
Sanchez	NULL
E	NULL
,	NULL
Kabbash	NULL
L	NULL
,	NULL
Asch	NULL
A	NULL
,	NULL
Gailit	NULL
J	NULL
,	NULL
Wright	NULL
SD	NULL
:	NULL
Cytokine-induced	NULL
respiratory	NULL
burst	NULL
of	NULL
hu-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

632	NULL
man	NULL
neutrophils	NULL
:	NULL
Dependence	NULL
on	NULL
extracellular	NULL
matrix	NULL
proteins	NULL
and	NULL
CDI11/CD18	NULL
integrins	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
109:1341	NULL
,	NULL
1989	NULL
31	NULL
.	NULL

Narayanan	NULL
R	NULL
,	NULL
Klement	NULL
JF	NULL
,	NULL
Ruben	NULL
SM	NULL
,	NULL
Higgins	NULL
KA	NULL
,	NULL
Rosen	NULL
CA	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
naturally	NULL
occurring	NULL
transforming	NULL
variant	NULL
of	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Science	NULL
256:367	NULL
,	NULL
1992	NULL
32	NULL
.	NULL

Bacuerle	NULL
PA	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
IkB	NULL
:	NULL
A	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:540	NULL
,	NULL
1988	NULL
33	NULL
.	NULL

Higgins	NULL
et	NULL
al	NULL
:	NULL
(	NULL
submitted	NULL
)	NULL
34	NULL
.	NULL

Pahl	NULL
HL	NULL
,	NULL
Rosmarin	NULL
AG	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
myeloid-specific	NULL
CD	NULL
11b	NULL
promoter	NULL
.	NULL

Blood	NULL
79:865	NULL
,	NULL
1992	NULL
SOKOLOSKI	NULL
ET	NULL
AL	NULL
35	NULL
.	NULL

Rosmarin	NULL
AG	NULL
,	NULL
Weil	NULL
SC	NULL
,	NULL
Rosner	NULL
GL	NULL
,	NULL
Griffin	NULL
JD	NULL
,	NULL
Arnaout	NULL
MA	NULL
,	NULL
Tenen	NULL
DG	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
CD11b/CD18	NULL
(	NULL
Mol	NULL
)	NULL
and	NULL
myeloperoxidase	NULL
genes	NULL
during	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Blood	NULL
73:131	NULL
,	NULL
1989	NULL
36	NULL
.	NULL

Bacuerle	NULL
P	NULL
:	NULL
The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
Regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1072:63	NULL
,	NULL
1991	NULL
37	NULL
.	NULL

Libermann	NULL
TA	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
Activation	NULL
of	NULL
IL-6	NULL
gene	NULL
expression	NULL
through	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
,	NULL
Mol	NULL
Cell	NULL
Biol	NULL
10:2327	NULL
,	NULL
1990	NULL
From	NULL
www	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
===	NULL
Antisense	NULL
oligonucleotides	NULL
to	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-kappa	NULL
B	NULL
block	NULL
CD11b	NULL
expression	NULL
and	NULL
alter	NULL
adhesion	NULL
properties	NULL
of	NULL
differentiated	NULL
HL-60	NULL
granulocytes	NULL
A	NULL
_	NULL
gs	NULL
%	NULL
p	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

C100	NULL
(	NULL
f	NULL
@	NULL
JA	NULL
Sokoloski	NULL
,	NULL
AC	NULL
Sartorelli	NULL
,	NULL
CA	NULL
Rosen	NULL
and	NULL
R	NULL
Narayanan	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/82/2/625.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

